Compare Ginkgo Bioworks Holdings Inc (DNA) vs Heron Therapeutics Inc (HRTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ginkgo Bioworks Holdings Inc vs Heron Therapeutics Inc — how do they compare? Ginkgo Bioworks Holdings Inc trades at $7.51 (market cap $505.73M), while Heron Therapeutics Inc trades at $0.32 (market cap $61.47M). The key difference: Ginkgo Bioworks Holdings Inc is far larger — about 8.2× Heron Therapeutics Inc's market cap, and Ginkgo Bioworks Holdings Inc is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals.
| DNA | HRTX | |
|---|---|---|
Market Cap | $505.73M | $61.47M |
Sector | Health | Health |
52-Week High | $16.14 | $1.49 |
52-Week Low | $5.48 | $0.32 |
Enterprise Value | $607.68M | $168.21M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →
